Progress in Development of Lung Cancer Screening Tools » Epigenetics News

10.11.06

Progress in Development of Lung Cancer Screening Tools

Posted in cancer, news links at 6:00 am by Trevor

Epigenomics AG recently announced that it has identified novel biomarkers that could be used in the development of clinical tests to aid in the early detection of lung cancer.

    …Epigenomics identified a large number of genes showing higher levels of DNA methylation in lung cancer compared to healthy lung tissue and other healthy and cancerous controls. The results were statistically significant. Importantly, a considerable number of these candidate DNA methylation biomarkers detected both major types of lung cancer, small cell lung cancer (SCLC) as well as non-small cell lung cancer (NSCLC). Link
Earlier this year a review was published summarizing the link between epigenetics and lung cancer.

Related Posts:

  • Lung cancer epigenetics and genetics.
  • Epigenomics AG Delivers Clinical Proof-of-Concept for Lung Cancer Detection
  • The Epigenetics of Lung Cancer
  • Roche Terminates Cancer Screening Collaboration with Epigenomics
  • Methylation Markers Found for Multiple Cancers

    • RSS feed

    Comments

    No comments yet.

    Sorry, the comment form is closed at this time.